These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26295863)

  • 1. Rosacea-like eruption due to topical pimecrolimus.
    El-Heis S; Buckley DA
    Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream.
    Gorman CR; White SW
    Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323
    [No Abstract]   [Full Text] [Related]  

  • 3. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol-induced flushing with topical pimecrolimus use.
    Ogunleye T; James WD
    Dermatitis; 2008; 19(2):E1-2. PubMed ID: 18413100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
    Chu CY
    Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
    Frankel A; Sohn A; Patel RV; Lebwohl M
    J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosaceiform eruption to pimecrolimus.
    El Sayed F; Ammoury A; Dhaybi R; Bazex J
    J Am Acad Dermatol; 2006 Mar; 54(3):548-50. PubMed ID: 16488319
    [No Abstract]   [Full Text] [Related]  

  • 8. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors.
    Shi VY; Joo JS; Sharon VR
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus-induced rosacea-like demodicidosis.
    Yoon TY; Kim HJ; Kim MK
    Int J Dermatol; 2007 Oct; 46(10):1103-5. PubMed ID: 17910727
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosaceiform dermatitis associated with topical tacrolimus treatment.
    Fujiwara S; Okubo Y; Irisawa R; Tsuboi R
    J Am Acad Dermatol; 2010 Jun; 62(6):1050-2. PubMed ID: 20466178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
    Werfel T
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.
    Firooz A; Solhpour A; Gorouhi F; Daneshpazhooh M; Balighi K; Farsinejad K; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Aug; 142(8):1066-7. PubMed ID: 16924062
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medication of the month. Topical pimecrolimus (Elidel)].
    Quatresooz P; Fumal I; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2003 Mar; 58(3):168-71. PubMed ID: 12723511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches.
    Nikolaou V; Stratigos A; Antoniou C; Kiagia M; Nikolaou C; Katsambas A; Syrigos K
    Dermatology; 2010; 220(3):243-8. PubMed ID: 20110632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.